Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA–IIIA non-small-cell lung cancer

By Kawamura Masafumi   Eguchi Keisuke   Izumi Yotaro   Yamato Yasushi   Koike Teruaki   Sakaguchi Hirozo   Hada Enjo   Kobayashi Koichi  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. : 495-501

Springer Publishing Company

Access to resources Recommend Favorite

DNA Index by Flow Cytometric Analysis: An Additional Prognostic Factor in Advanced Ovarian Carcinoma without Residual Disease after Primary Operation

By Zanetta G.   Keeney G.L.   Cha S.S.   Wieand H.S.   Katzmann J.A.   Podratz K.C.  

Gynecologic Oncology, Vol. 62, Iss. 2, 1996-08 ,pp. : 208-212

Academic Press

Access to resources Recommend Favorite

Prognostic Factors in Patients with Bulky Stage IB or IIA Cervical Carcinoma Undergoing Neoadjuvant Chemotherapy and Radical Hysterectomy

By Lai C.-H.   Hsueh S.   Chang T.-C.   Tseng C.-J.   Huang K.-G.   Chou H.-H.   Chen S.-M.   Chang M.-F.   Shum H.-C.  

Gynecologic Oncology, Vol. 64, Iss. 3, 1997-03 ,pp. : 456-462

Elsevier

Access to resources Recommend Favorite

Stage IIa Cervix Carcinoma with Metastasis to the Heart: Report of a Case with Immunohistochemistry, Flow Cytometry, and Virology Findings

By Sergi C.   Magener A.   Ehemann V.   De Villiers E.-M.   Sinn H.-P.  

Gynecologic Oncology, Vol. 76, Iss. 1, 2000-01 ,pp. : 133-138

Elsevier

Access to resources Recommend Favorite

Identification of High-Risk Groups among Node-Positive Patients with Stage IB and IIA Cervical Carcinoma

By Samlal R.A.K.   van der Velden J.   Schilthuis M.S.   Gonzalez D.G.   Ten Kate F.J.W.   Hart A.A.M.   Lammes F.B.  

Gynecologic Oncology, Vol. 64, Iss. 3, 1997-03 ,pp. : 463-467

Elsevier

Access to resources Recommend Favorite